Tirzepatide (Mounjaro and Zepbound) is a dual GLP-1/GIP receptor agonist approved by the FDA for managing blood sugar levels (Mounjaro) and chronic weight management (Zepbound)
Also checking this is extremely hard. Unwitting Guinea Pigs for Untested Substances The thought of otherwise young healthy individuals taking such products is extremely distressing, Amy Eichner, of the U.S
rather, within this framework, observed clinical phenomena may reflect contributions from peripheral modulation, central integration, and state-dependent processes to varying degrees across treatment stages, influencing multiple nodes including sensory, liking, and wanting, and ultimately shaping food intake and body-weight outcomes (11)
Taking blood pressure medication alongside rapid weight loss may lead to levels that are too low, causing dizziness